scispace - formally typeset
C

Carmelo Gaudioso

Researcher at Roswell Park Cancer Institute

Publications -  18
Citations -  24023

Carmelo Gaudioso is an academic researcher from Roswell Park Cancer Institute. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 8, co-authored 16 publications receiving 20142 citations. Previous affiliations of Carmelo Gaudioso include National Institutes of Health.

Papers
More filters
Journal ArticleDOI

Comprehensive molecular portraits of human breast tumours

Daniel C. Koboldt, +355 more
- 04 Oct 2012 - 
TL;DR: The ability to integrate information across platforms provided key insights into previously defined gene expression subtypes and demonstrated the existence of four main breast cancer classes when combining data from five platforms, each of which shows significant molecular heterogeneity.
Journal ArticleDOI

Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network

Eric A. Collisson, +318 more
- 01 Jan 2014 - 
TL;DR: In this paper, the authors report molecular profiling of 230 resected lung adnocarcinomas using messenger RNA, microRNA and DNA sequencing integrated with copy number, methylation and proteomic analyses.
Journal ArticleDOI

Comprehensive genomic characterization of squamous cell lung cancers

Peter S. Hammerman, +345 more
- 27 Sep 2012 - 
TL;DR: It is shown that the tumour type is characterized by complex genomic alterations, with a mean of 360 exonic mutations, 165 genomic rearrangements, and 323 segments of copy number alteration per tumour.
Journal ArticleDOI

Comprehensivemolecular characterization of clear cell renal cell carcinoma

Chad J. Creighton, +291 more
- 28 Aug 2013 - 
TL;DR: Remodelling cellular metabolism constitutes a recurrent pattern in ccRCC that correlates with tumour stage and severity and offers new views on the opportunities for disease treatment.
Journal ArticleDOI

Genomic Classification of Cutaneous Melanoma

Rehan Akbani, +351 more
- 18 Jun 2015 - 
TL;DR: This clinicopathological and multi-dimensional analysis suggests that the prognosis of melanoma patients with regional metastases is influenced by tumor stroma immunobiology, offering insights to further personalize therapeutic decision-making.